Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

David G. Pfister; Sharon Spencer; David M. Brizel; Barbara Burtness; Paul M. Busse; Jimmy J. Caudell; Anthony J. Cmelak; A. Dimitrios Colevas; Frank Dunphy; David W. Eisele; Robert L. Foote; Jill Gilbert; Maura L. Gillison; Robert I. Haddad; Bruce H. Haughey; Wesley L. Hicks; Ying J. Hitchcock; Antonio Jimeno; Merrill S. Kies; William M. Lydiatt; Ellie Maghami; Thomas McCaffrey; Loren K. Mell; Bharat B. Mittal; Harlan A. Pinto; John A. Ridge; Cristina P. Rodriguez; Sandeep Samant; Jatin P. Shah; Randal S. Weber; Gregory T. Wolf; Frank Worden; Sue S. Yom; Nicole McMillian; Miranda Hughes

doi:10.6004/jnccn.2015.0102

Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

David G. Pfister, Sharon Spencer, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Robert L. Foote, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Merrill S. Kies, William M. LydiattEllie Maghami, Thomas McCaffrey, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Cristina P. Rodriguez, Sandeep Samant, Jatin P. Shah, Randal S. Weber, Gregory T. Wolf, Frank Worden, Sue S. Yom, Nicole McMillian, Miranda Hughes

Research output: Contribution to journal › Article › peer-review

181 Scopus citations

Abstract

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.

Original language	English (US)
Pages (from-to)	847-856
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	13
Issue number	7
DOIs	https://doi.org/10.6004/jnccn.2015.0102
State	Published - Jul 1 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2015.0102

Cite this

Pfister, D. G., Spencer, S., Brizel, D. M., Burtness, B., Busse, P. M., Caudell, J. J., Cmelak, A. J., Colevas, A. D., Dunphy, F., Eisele, D. W., Foote, R. L., Gilbert, J., Gillison, M. L., Haddad, R. I., Haughey, B. H., Hicks, W. L., Hitchcock, Y. J., Jimeno, A., Kies, M. S., ... Hughes, M. (2015). Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 13(7), 847-856. https://doi.org/10.6004/jnccn.2015.0102

Pfister, DG, Spencer, S, Brizel, DM, Burtness, B, Busse, PM, Caudell, JJ, Cmelak, AJ, Colevas, AD, Dunphy, F, Eisele, DW, Foote, RL, Gilbert, J, Gillison, ML, Haddad, RI, Haughey, BH, Hicks, WL, Hitchcock, YJ, Jimeno, A, Kies, MS, Lydiatt, WM, Maghami, E, McCaffrey, T, Mell, LK, Mittal, BB, Pinto, HA, Ridge, JA, Rodriguez, CP, Samant, S, Shah, JP, Weber, RS, Wolf, GT, Worden, F, Yom, SS, McMillian, N & Hughes, M 2015, 'Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 7, pp. 847-856. https://doi.org/10.6004/jnccn.2015.0102

@article{b3a3e2d47f3b460f890ad015238ad98e,

title = "Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines",

abstract = "These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.",

author = "Pfister, {David G.} and Sharon Spencer and Brizel, {David M.} and Barbara Burtness and Busse, {Paul M.} and Caudell, {Jimmy J.} and Cmelak, {Anthony J.} and Colevas, {A. Dimitrios} and Frank Dunphy and Eisele, {David W.} and Foote, {Robert L.} and Jill Gilbert and Gillison, {Maura L.} and Haddad, {Robert I.} and Haughey, {Bruce H.} and Hicks, {Wesley L.} and Hitchcock, {Ying J.} and Antonio Jimeno and Kies, {Merrill S.} and Lydiatt, {William M.} and Ellie Maghami and Thomas McCaffrey and Mell, {Loren K.} and Mittal, {Bharat B.} and Pinto, {Harlan A.} and Ridge, {John A.} and Rodriguez, {Cristina P.} and Sandeep Samant and Shah, {Jatin P.} and Weber, {Randal S.} and Wolf, {Gregory T.} and Frank Worden and Yom, {Sue S.} and Nicole McMillian and Miranda Hughes",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2015",

month = jul,

day = "1",

doi = "10.6004/jnccn.2015.0102",

language = "English (US)",

volume = "13",

pages = "847--856",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "7",

}

TY - JOUR

T1 - Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

AU - Pfister, David G.

AU - Spencer, Sharon

AU - Brizel, David M.

AU - Burtness, Barbara

AU - Busse, Paul M.

AU - Caudell, Jimmy J.

AU - Cmelak, Anthony J.

AU - Colevas, A. Dimitrios

AU - Dunphy, Frank

AU - Eisele, David W.

AU - Foote, Robert L.

AU - Gilbert, Jill

AU - Gillison, Maura L.

AU - Haddad, Robert I.

AU - Haughey, Bruce H.

AU - Hicks, Wesley L.

AU - Hitchcock, Ying J.

AU - Jimeno, Antonio

AU - Kies, Merrill S.

AU - Lydiatt, William M.

AU - Maghami, Ellie

AU - McCaffrey, Thomas

AU - Mell, Loren K.

AU - Mittal, Bharat B.

AU - Pinto, Harlan A.

AU - Ridge, John A.

AU - Rodriguez, Cristina P.

AU - Samant, Sandeep

AU - Shah, Jatin P.

AU - Weber, Randal S.

AU - Wolf, Gregory T.

AU - Worden, Frank

AU - Yom, Sue S.

AU - McMillian, Nicole

AU - Hughes, Miranda

PY - 2015/7/1

Y1 - 2015/7/1

N2 - These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.

AB - These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.

UR - http://www.scopus.com/inward/record.url?scp=84938055154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938055154&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2015.0102

DO - 10.6004/jnccn.2015.0102

M3 - Article

C2 - 26150579

AN - SCOPUS:84938055154

SN - 1540-1405

VL - 13

SP - 847

EP - 856

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 7

ER -

Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this